Liquid biopsy: blood‐based analyses of circulating cell‐free DNA in xenografts
The liquid biopsy concept has been introduced for circulating tumor cells more than 10 years ago (Pantel & Alix‐Panabieres, 2010) and rapidly extended to cell‐free DNA released from tumor cells (ctDNA; Lo et al, 2021) and other tumor‐derived products such as circulating cell‐free RNA (noncoding and messenger RNA), extracellular vesicles, or tumor‐educated platelets (Alix‐Panabières & Pantel, 2021). In this issue of EMBO Molecular Medicine, the report of Sauer et al (2022) demonstrates the feasibility of longitudinal monitoring of disease burden and response using ctDNA from dried blood spots in xenograft models.
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Liquid biopsy: blood‐based analyses of circulating cell‐free DNA in xenografts ; day:29 ; month:07 ; year:2022 ; extent:3
EMBO molecular medicine / European Molecular Biology Organization ; (29.07.2022) (gesamt 3)
- Creator
-
Heidrich, Isabel
Pantel, Klaus
- DOI
-
10.15252/emmm.202216326
- URN
-
urn:nbn:de:101:1-2022072915210954439666
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:37 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Heidrich, Isabel
- Pantel, Klaus
Other Objects (12)
Noninvasive multi-cancer detection using blood-based cell-free microRNAs
Circulating tumor cells (CTCs) and circulating cell-free tumor DNA (ctDNA) as blood-based biomarkers for managing non-small cell lung cancer (NSCLC) patients
Cell-free circulating tumor DNA in cancer
Quantifying circulating cell-free DNA in humans
Liquid Biopsy - Blood-based biomarkers for the molecular analysis of cancer
Circulating cell-free DNA use for diagnosing cholangiocarcinoma
Discovery and validation of methylation signatures in blood-based circulating tumor cell-free DNA in early detection of colorectal carcinoma: a case–control study
Circulating nucleosomes as new blood-based biomarkers for detection of colorectal cancer
Liquid biopsy and circulating free plasma DNA
Circulating cell-free DNA and circulating tumor cells, the “liquid biopsies” in ovarian cancer
Liquid biopsy in mice bearing colorectal carcinoma xenografts: gateways regulating the levels of circulating tumor DNA (ctDNA) and miRNA (ctmiRNA)
Liquid biopsy posttreatment surveillance in endemic nasopharyngeal carcinoma: a cost-effective strategy to integrate circulating cell-free Epstein-Barr virus DNA
Noninvasive multi-cancer detection using blood-based cell-free microRNAs
Circulating tumor cells (CTCs) and circulating cell-free tumor DNA (ctDNA) as blood-based biomarkers for managing non-small cell lung cancer (NSCLC) patients
Cell-free circulating tumor DNA in cancer
Quantifying circulating cell-free DNA in humans
Liquid Biopsy - Blood-based biomarkers for the molecular analysis of cancer
Circulating cell-free DNA use for diagnosing cholangiocarcinoma
Discovery and validation of methylation signatures in blood-based circulating tumor cell-free DNA in early detection of colorectal carcinoma: a case–control study
Circulating nucleosomes as new blood-based biomarkers for detection of colorectal cancer
Liquid biopsy and circulating free plasma DNA
Circulating cell-free DNA and circulating tumor cells, the “liquid biopsies” in ovarian cancer
Liquid biopsy in mice bearing colorectal carcinoma xenografts: gateways regulating the levels of circulating tumor DNA (ctDNA) and miRNA (ctmiRNA)
Liquid biopsy posttreatment surveillance in endemic nasopharyngeal carcinoma: a cost-effective strategy to integrate circulating cell-free Epstein-Barr virus DNA
Noninvasive multi-cancer detection using blood-based cell-free microRNAs
Circulating tumor cells (CTCs) and circulating cell-free tumor DNA (ctDNA) as blood-based biomarkers for managing non-small cell lung cancer (NSCLC) patients
Cell-free circulating tumor DNA in cancer
Quantifying circulating cell-free DNA in humans
Liquid Biopsy - Blood-based biomarkers for the molecular analysis of cancer
Circulating cell-free DNA use for diagnosing cholangiocarcinoma
Discovery and validation of methylation signatures in blood-based circulating tumor cell-free DNA in early detection of colorectal carcinoma: a case–control study
Circulating nucleosomes as new blood-based biomarkers for detection of colorectal cancer
Liquid biopsy and circulating free plasma DNA
Circulating cell-free DNA and circulating tumor cells, the “liquid biopsies” in ovarian cancer
Liquid biopsy in mice bearing colorectal carcinoma xenografts: gateways regulating the levels of circulating tumor DNA (ctDNA) and miRNA (ctmiRNA)